Hezong Science&Technology Co Intangible Assets
The Intangible Assets of Hezong Science&Technology Co (300477.SZ) as of Oct 10, 2026 is 537.85 M CNY. In the previous year, Intangible Assets was 653.59 M CNY — a change of -17.71% (lower).
Get this data via API
Financial Data API
Intangible Assets
537.85 MCNY
YoY
-17.71%
Last updated:
The Hezong Science&Technology Co Intangible Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Intangible Assets | YoY |
|---|---|---|
| 537.85 MCNY | -17.71% | |
| 653.59 MCNY | +122.99% | |
| 293.10 MCNY | +15.92% | |
| 252.85 MCNY | -1.54% | |
| 256.80 MCNY | -1.80% | |
| 261.50 MCNY | +21.97% | |
| 214.40 MCNY | +1.52% | |
| 211.20 MCNY | +42.90% | |
| 147.80 MCNY | +15.47% | |
| 128.00 MCNY | +357.14% | |
| 28.00 MCNY | — |
Hezong Science&Technology Co Stock analysis
Frequently Asked Questions about Hezong Science&Technology Co stock
Intangible Assets of Hezong Science&Technology Co is 537.85 M CNY in 2024.
Intangible Assets of Hezong Science&Technology Co changed from 653.59 M CNY to 537.85 M CNY, representing a -17.71% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Intangible Assets Hezong Science&Technology Co since 2006 – with annual values, charts, and detailed analysis.
Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.
Intangible Assets's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Hezong Science&Technology Co historically and in real time.
Balance Sheet — Hezong Science&Technology Co
All Key Metrics — Hezong Science&Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth